Senior Director/Director, Product Marketing
About this role
Cytovale is a leading innovator in early sepsis detection, revolutionizing emergency care with its advanced IntelliSep technology. This system provides rapid, actionable insights into a patient's likelihood of having or developing sepsis through a quick 8-minute blood test. IntelliSep's unique capability to assess immune dysregulation enhances the triage and treatment of sepsis, promoting patient-centered care, operational efficiencies, and provider satisfaction. Cytovale is committed to the successful implementation, clinical adoption, and continual improvement of healthcare outcomes. For more information, please visit www.cytovale.com.
Position Overview:
Cytovale is seeking a Senior Director /Director of Product Marketing to own the strategy, positioning, and go-to-market execution for IntelliSep as the company scales commercial adoption across health systems nationally. This is a senior, highly cross-functional role that sits at the intersection of clinical evidence, market access, sales enablement, and brand strategy. The ideal candidate is a player/coach, willing and capable of rolling up their sleeves and doing the work, but has also built product marketing functions inside commercial-stage medical device or diagnostics companies and is comfortable packaging up services and translating complex clinical and health economic data into messaging that resonates with hospital system administrators, clinicians, and staff.
Key Responsibilities:
Positioning and Messaging
- Own IntelliSep's core value proposition and messaging architecture across clinical (ED physicians, nurses, sepsis coordinators), staff (lab, IT), economic (CFO, CQO, CMO), and payer audiences.
- Translate clinical outcomes data (mortality reduction, length of stay, antibiotic stewardship) into differentiated, defensible messaging that holds up under clinical and health economic scrutiny.
- Partner with Medical Affairs to ensure messaging stays aligned with the latest peer-reviewed evidence and guideline developments.
- Lead launch and lifecycle marketing plans for new indications, clinical data, claims, or product enhancements.
- Define and prioritize target segments and personas in partnership with Sales and Market Access, informed by ED volume, sepsis program maturity, and payer mix.
- Own competitive intelligence and positioning against alternative sepsis diagnostic and risk-stratification approaches.
- Build and maintain the sales toolkit: value propositions, objection handling, ROI/pricing tools, clinical evidence summaries, and battlecards.
- Partner with Sales Leadership and Sales Enablement to train field teams on new messaging, data, and competitive developments.
- Support key account and KOL engagement strategy in partnership with Medical Affairs and Market Access.
- Collaborate with Market Access to align product marketing materials with coding, coverage, and reimbursement narratives, and (e.g., CPT/HCPCS, gapfill pricing, payer-specific value stories).
- Develop payer-facing materials that support payer engagements and value-based contracting conversations.
- Own brand strategy and visual identity guardrails for IntelliSep across conferences, digital, and field materials.
- Guide content strategy across channels (LinkedIn, email, web, conference activations) with support from a marketing content/demand gen team.
- Oversee flagship conference presence (e.g., ADLM, SCCM, ACEP), including KOL programming, dinner events, and booth strategy.
- Build, mentor, and scale a product marketing team as the commercial organization grows.
- Serve as a key voice in cross-functional planning with R&D, Regulatory, Medical Affairs, Market Access, and Sales.
- Present product marketing strategy and results to executive leadership and the board as needed.
- 8-15+ years of marketing experience, including 5+ years in product marketing at a medical device, diagnostics, or life sciences company; commercial-stage IVD experience strongly preferred.
- Experience marketing to both clinical and economic buyers in a hospital setting; acute care, ED, or critical care experience is a strong plus.
- Track record of translating clinical evidence and health economics into commercial messaging that withstands scrutiny from clinicians, KOLs, and payers.
- Experience supporting reimbursement and market access narratives (coding, coverage, payer engagement) is a plus.
- Strong cross-functional leadership skills, with experience partnering closely with Sales, Medical Affairs, Market Access, Sales Enablement, and Regulatory in a matrixed environment.
- Excellent written and verbal communication skills, with sharp editorial judgment for clinical and commercial content.
- Experience building or scaling a product marketing function, including team leadership.
- Bachelor's degree required; MBA or advanced clinical/scientific degree a plus.
- A standard of care changed, lives saved, hospital system operations improved.
- Clear, differentiated, and clinically credible messaging adopted consistently across sales, marketing, and medical affairs materials.
- Measurable improvement in sales team confidence and win rates tied to enablement tools.
- Strong conference and KOL program execution that generates qualified pipeline.
- Messaging and materials that hold up under payer and guideline body scrutiny, supporting market access efforts.
- A scaling product marketing function with clear processes and growing team capability.
Cytovale Culture:
We’re looking for a leader who will thrive in Cytovale’s environment. The ideal candidate will be:
- Comfortable with ambiguity: You can move forward without perfect information and adjust quickly as new data emerges.
- High ownership, low ego: You take accountability for outcomes, seek feedback, and care more about impact than credit.
- Execution-focused: you don’t just build strategies; you deliver results, iterate fast, and follow through.
- Intellectually curious: You enjoy digging into data, asking hard questions, and continuously improving your understanding.
- Resilient and adaptable: You stay steady and effective in a fast-paced, evolving environment.
- Mission-driven: You are motivated by Cytovale’s goal to improve outcomes for patients and want your work to matter.
Company at a glance
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes.
Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential.
Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful.
Follow us on Twitter: twitter.com/cytovale
Tired of cold applications?
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Know someone who'd be great for this?